Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Oncoimmunology|August 5, 2021
Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphomaHua You, Zijun Y Xu-Monette, Li Wei, et al.
Blood|May 16, 2024
Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD studyChiara Malinverni, Andrea Bernardelli, Ingrid Glimelius, et al.
Oncotarget|September 2, 2015
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphomaLing Li, Zijun Y Xu-Monette, Chi Young Ok, et al.
Leukemia|August 13, 2020
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST studyCarlo Visco, Alice Di Rocco, Andrea Evangelista, et al.
Aging|February 17, 2016
p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor functionZijun Y Xu-Monette, Shanxiang Zhang, Xin Li, et al.
Oncoimmunology|August 7, 2024
DNA mismatch repair defect and intratumor heterogeneous deficiency differently impact immune responses in diffuse large B-cell lymphomaZijun Y Xu-Monette, Cancan Luo, Li Yu, et al.
Blood|March 22, 2013
Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium ProgramYong Li, Michael W Gordon, Zijun Y Xu-Monette, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2015
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functionsChi Young Ok, Zijun Y Xu-Monette, Ling Li, et al.
Oncotarget|February 24, 2015
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphomaJiayu Chen, Zijun Y Xu-Monette, Lijuan Deng, et al.
Lancet (London, England)|May 5, 2024
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma NetworkMartin Dreyling, Jeanette Doorduijn, Eva Giné, et al.
Pageof 17